The FDA has cleared the first blood test to aid in diagnosis of Alzheimer’s. The test detects amyloid plaques, a hallmark of the disease, through a blood draw.
“Today marks another important step in Alzheimer’s disease diagnosis,” said @DrMariaALZ. “With today’s action by the FDA we are hopeful it will be easier for more individuals to receive an accurate diagnosis earlier.”
While there is no single, stand-alone test to diagnose Alzheimer’s disease today — including this newly approved test — blood testing can be an important piece of the diagnostic process.
The Association is leading the development of clinical practice guidelines for the use of blood biomarker tests in specialty care settings, which will be debuted this summer at the #AAIC25, July 27-31 in Toronto and online.
Read our full statement: https://t.co/8oedt6zD2Z
Aluna da UFRGS é reconhecida como mais promissora pesquisadora do mundo. Giovanna Carello Collar recebeu o prêmio "One to Watch", na Conferência Internacional da Associação de Alzheimer.
https://t.co/6m5bZbEc8J
Also wanna express my gratitude to colleagues and everyone who stopped by my poster 💜 and of course the @alzassociation for giving me the opportunity to come and inspiring me to keep working with what I love 💜
First time and first in person poster at @alzassociation . Thank you for @erzimmer, @limberger_chris for mentoring me and for believing in me. I’m so grateful to have inspiring people by my side 💜. +++
Undergraduate student @beta1507 received a travel award to present a poster for the first time at #AAIC24@alzassociation.
Congratulations, Roberta! Here she is in the photo with her co-supervisor, @limberger_chris.
@limberger_chris, a PhD student at @zimmerneurolab, presents a poster showing that 'Metabolic PET brain networks are affected prior to clinical conversion in Alzheimer's disease'. #AAIC24
Congratulations to @BellaverBruna@LabPascoal on receiving Publication of the Year Award in the biofluid biomarkers category from the Alzheimer's Association for this work!